Drug Profile
RO 600332
Alternative Names: ORG 35035Latest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Anxiolytics
- Mechanism of Action Serotonin 2C receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Depression in Switzerland (unspecified route)
- 08 Nov 2006 Discontinued - Preclinical for Erectile dysfunction in Europe (unspecified route)
- 08 Nov 2006 Discontinued - Preclinical for Obsessive-compulsive disorders in Switzerland (unspecified route)